Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease

Summary:

A retrospective chart review was performed on seven patients treated with topical ocular corticosteroid therapy for progressive cicatricial conjunctivitis associated with chronic graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation. A clinical grading criteria for conjunctival GVHD based on the degree of cicatrization was developed and patients graded prior to therapy. During the treatment course, the dose and frequency of topical corticosteroids and clinical outcomes were recorded. A complete response was defined as a complete resolution of the conjunctival hyperemia with either total resolution of the conjunctival fibrovascularization or presence of inactive conjunctival scarring. Prednisolone acetate 1% eye drops were used in a total of eight courses of therapy in seven patients. A complete response was documented in all seven patients with a total treatment duration of 7 weeks (median, range: 3–16 weeks). Additional studies are required to determine the long-term safety and efficacy of topical corticosteroids for cicatricial conjunctivitis associated with ocular GVHD in the context of a randomized, prospective clinical trial.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Young NS, Barrett AJ . The treatment of severe acquired aplastic anemia. Blood 1995; 85: 3367–3377.

    CAS  PubMed  Google Scholar 

  2. Barrett AJ, van Rhee F . Graft-versus-leukaemia. Baillieres Clin Haematol 1997; 10: 337–355.

    Article  CAS  Google Scholar 

  3. Childs RW . Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation. Med Gen Med 2002; 4: 13.

    Google Scholar 

  4. Burt RK, Traynor AE, Craig R, Marmont AM . The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003; 31: 521–524.

    Article  CAS  Google Scholar 

  5. Vogelsang GB, Lee L, Bensen-Kennedy DM . Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003; 54: 29–52.

    Article  CAS  Google Scholar 

  6. Hirst LW, Jabs DA, Tutschka PJ et al. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983; 101: 580–584.

    Article  CAS  Google Scholar 

  7. Franklin RM, Kenyon KR, Tutschka PJ et al. Ocular manifestations of graft-vs-host disease. Ophthalmology 1983; 90: 4–13.

    Article  CAS  Google Scholar 

  8. Jack MK, Jack GM, Sale GE et al. Ocular manifestations of graft-v-host disease. Arch Ophthalmol 1983; 101: 1080–1084.

    Article  CAS  Google Scholar 

  9. Jabs DA, Wingard J, Green WR et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107: 1343–1348.

    Article  CAS  Google Scholar 

  10. Livesey SJ, Holmes JA, Whittaker JA . Ocular complications of bone marrow transplantation. Eye 1989; 3 (Part 3): 271–276.

    Article  Google Scholar 

  11. Bray LC, Carey PJ, Proctor SJ et al. Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991; 75: 611–614.

    Article  CAS  Google Scholar 

  12. Marzano AV, Facchetti M, Berti E, Caputo R . Chronic graft-vs-host disease with severe cicatrizing conjunctivitis mimicking cicatricial pemphigoid. Br J Dermatol 2000; 143: 209–210.

    Article  CAS  Google Scholar 

  13. Heath JD, Acheson JF, Schulenburg WE . Penetrating keratoplasty in severe ocular graft versus host disease. Br J Ophthalmol 1993; 77: 525–526.

    Article  CAS  Google Scholar 

  14. Peris-Martinez C, Menezo JL, Diaz-Llopis M et al. Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 2001; 11: 183–186.

    Article  CAS  Google Scholar 

  15. Ogawa Y, Okamoto S, Kuwana M et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea 2001; 20: 430–434.

    Article  CAS  Google Scholar 

  16. Vogelsang GB . How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196–1201.

    Article  CAS  Google Scholar 

  17. Ahmad SM, Stegman Z, Fructhman S, Asbell PA . Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506). Cornea 2002; 21: 432–433.

    Article  Google Scholar 

  18. Kiang E, Tesavibul N, Yee R et al. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant 1998; 22: 147–151.

    Article  CAS  Google Scholar 

  19. Janin A, Facon T, Castier P et al. Pseudomembranous conjunctivitis following bone marrow transplantation: immunopathological and ultrastructural study of one case. Hum Pathol 1996; 27: 307–309.

    Article  CAS  Google Scholar 

  20. Kerty E, Vigander K, Flage T, Brinch L . Ocular findings in allogeneic stem cell transplantation without total body irradiation. Ophthalmology 1999; 106: 1334–1338.

    Article  CAS  Google Scholar 

  21. Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  Google Scholar 

  22. Bertz H, Afting M, Kreisel W et al. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD. Bone Marrow Transplant 1999; 24: 1185–1189.

    Article  CAS  Google Scholar 

  23. Akpek G, Lee SM, Anders V, Vogelsang GB . A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biol Blood Marrow Transplant 2001; 7: 495–502.

    Article  CAS  Google Scholar 

  24. Kupferman A, Leibowitz HM . Biological equivalence of ophthalmic prednisolone acetate suspensions. Am J Ophthalmol 1976; 82: 109–113.

    Article  CAS  Google Scholar 

  25. Migita K, Eguchi K, Kawabe Y et al. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation 1997; 63: 583–587.

    Article  CAS  Google Scholar 

  26. Buttgereit F, Wehling M, Burmester GR . A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998; 41: 761–767.

    Article  CAS  Google Scholar 

  27. Bhan AK, Fujikawa LS, Foster CS . T-cell subsets and Langerhans cells in normal and diseased conjunctiva. Am J Ophthalmol 1982; 94: 205–212.

    Article  CAS  Google Scholar 

  28. Ogawa Y, Kuwana M, Yamazaki K et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003; 44: 1888–1896.

    Article  Google Scholar 

  29. McGhee CN, Dean S, Danesh-Meyer H . Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002; 25: 33–55.

    Article  CAS  Google Scholar 

  30. Fraunfelder FT, Fraunfelder FW, Randall JA . Drug-Induced Ocular Side Effects, 5th edn. Butterworth-Heinemann: Boston, 2001, 349–360.

    Google Scholar 

  31. Maitchouk DY, Beuerman RW, Ohta T et al. Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys. Arch Ophthalmol 2000; 118: 246–252.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M R Robinson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, M., Lee, S., Rubin, B. et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 33, 1031–1035 (2004). https://doi.org/10.1038/sj.bmt.1704453

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704453

Keywords

This article is cited by

Search

Quick links